DOSAGE AND ADMINISTRATION7 INCRUSE

DOSAGE AND ADMINISTRATION
7 INCRUSE ELLIPTA (umeclidinium 62.5 mcg) should be administered as 1 inhalation
8 once daily by the orally inhaled route only.
9 INCRUSE ELLIPTA should be taken at the same time every day. Do not use INCRUSE
ELLIPTA more than 1 time every 24 hours.
11 No dosage adjustment is required for geriatric patients, patients with renal impairment, or
12 patients with moderate hepatic impairment [see Clinical Pharmacology (12.3)].